Papers
1
Total Citations
46
H-Index
1
About
Vanina Grippo is a leading researcher in molecular immunology and antibody engineering, with a focus on developing novel therapeutic strategies against HIV-1. Her most cited work, "Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1" (2014, 46 citations), represents a landmark contribution to the field. In this study, Grippo and her team demonstrated that llamas can generate heavy chain-only antibodies (HCAb) capable of broadly neutralizing HIV-1, a feat that had eluded traditional immunization approaches in humans and other animals. By mapping the molecular evolution of these antibodies, she provided critical insights into how the immune system can target the conserved CD4-binding site of the virus, offering a new pathway for vaccine design. This work has been widely cited for its innovative use of camelid immunology to overcome HIV-1’s notorious immune evasion. Grippo’s research bridges fundamental immunology and translational medicine, and her findings have inspired subsequent efforts to engineer nanobodies for HIV prevention and therapy. Her contributions underscore the potential of unconventional antibody formats in tackling some of the most challenging infectious diseases.
Research Focus
Key Achievements
Top Papers
- 1